ÂÜÀòÂÒÂ×

Elik Chapnik is a seasoned professional in business development and life sciences, currently serving as Vice President of Business Development at Yeda - Technology Transfer Company of Weizmann Institute of Science since June 2020, specializing in the commercialization of innovative technologies. With experience spanning various roles, including Senior Director at Yeda R&D, Director of Early Development at Quark Pharmaceuticals, and Sr. Manager in Translational Medicine and Clinical Development at Teva Pharmaceuticals, Elik has contributed to significant advancements in the biopharmaceutical sector. In addition, Elik holds board observer positions at Scala Biodesign, ProFuse Technology, and Renewal Bio, while also engaging in educational initiatives at the Davidson Institute of Science Education. Elik's academic background includes a PhD in Molecular Genetics and an MSc in Developmental Biology from the Weizmann Institute of Science, complemented by a BSc in Computational Biology from Bar-Ilan University.